Join
Live feed
·
NEWSReleasevia Quantisnow
MyMD Pharmaceuticals Inc. logo
PharmaCyte  Biotech Inc. logo

PharmaCyte Biotech Makes $7M Investment In MyMD Pharmaceuticals; Investment In Life Sciences Solidifies Previously Announced Strategy To Utilize Significant Cash Position To Create Additional Stockholder Value

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYMD (MyMD Pharmaceuticals Inc.), PMCB (PharmaCyte Biotech Inc.) and more on Quantisnow.